Serum leptin levels in obstructive sleep apnoea patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
Plasma orexin-A levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Serum resistin level in pediatric obstructive sleep apnea Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases Year: 2008
Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Serum omentin levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Serum fibrinogen in patients with obstructive sleep apnea Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020
Does low plasma adiponectin level affect cardiovasculer risk in obstructive sleep apnea syndrome? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Serum aminotransferase levels in patients with severe obstructive sleep apnea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
C-reactive protein levels in obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Elevated leptin is associated with impaired glucose tolerance in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 573s Year: 2006
Associations between increased serum leptin levels and the severity of obstructive sleep apnoea independent of obesity Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
The impact of serum leptin and soluble leptin receptor (sOB-R) levels on respiratory chemosensitivities in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006